pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda recalls·15h ago·1 min read
save

Victory Medical Center Pharmacy recalls glutathione vials over high endotoxin levels

Aug 5, 2026·read at fda recalls ↗CRLNegative

Victory Medical Center Pharmacy in Austin announced a voluntary recall of specific lots of its compounded glutathione 200 mg/mL multi‑dose vials.

Testing at the pharmacy detected elevated bacterial endotoxin levels, which can trigger serious medical reactions such as fever, hypotension, inflammatory responses, anaphylactic shock, and even death.

The company has received reports of adverse events including fever, chills, severe headache, nausea, vomiting, rapid heart rate, blood pressure changes, body aches, and injection‑site reactions.

The recalled product, lot numbers 1980571, 1981940 and 1984345, was distributed to patients in Texas, Florida and New York and will be removed from use. Victory Medical Center Pharmacy is contacting prescribers and patients by phone and mail.

source

This writeup was produced by pharmadog from original reporting by fda recalls.

Original headline: “Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels”

read at fda recalls ↗
398 words · retrieved 14h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Recall5Hematology2Cardiology

related stories

  • Jul 24American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matterfda recalls
  • Jul 1412 ideas for tackling the U.S. alcohol epidemicSTAT
  • Jun 1The hidden history of BPC-157, a favorite MAHA peptideSTAT
  • Jun 5Generic drugmakers gain key victory in ‘skinny label’ patent caseBioPharma Dive
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT